Galenica Sante AG (SW:GALE) — Market Cap & Net Worth
Market Cap & Net Worth: Galenica Sante AG (GALE)
Galenica Sante AG (SW:GALE) has a market capitalization of $4.09 Billion (CHF3.24 Billion) as of September 17, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #4051 globally and #61 in its home market, demonstrating a -0.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Galenica Sante AG's stock price CHF82.50 by its total outstanding shares 49824384 (49.82 Million). Also see Galenica Sante AG total assets for a full breakdown of the balance sheet.
Galenica Sante AG Market Cap History: 2017 to 2026
Galenica Sante AG's market capitalization history from 2017 to 2026. Data shows growth from $2.75 Billion to $5.20 Billion (8.99% CAGR). Also see GALE cash flow metrics for how efficiently the company converts equity into cash flow.
Galenica Sante AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Galenica Sante AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Galenica Sante AG for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.49x
Galenica Sante AG's market cap is 1.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
33.98x
Galenica Sante AG's market cap is 33.98 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $2.75 Billion | $3.15 Billion | $118.80 Million | 0.88x | 23.19x |
| 2018 | $2.46 Billion | $3.17 Billion | $147.55 Million | 0.77x | 16.65x |
| 2019 | $3.51 Billion | $3.31 Billion | $124.99 Million | 1.06x | 28.11x |
| 2020 | $3.51 Billion | $3.48 Billion | $172.25 Million | 1.01x | 20.37x |
| 2021 | $4.13 Billion | $3.83 Billion | $167.68 Million | 1.08x | 24.66x |
| 2022 | $4.62 Billion | $4.01 Billion | $165.13 Million | 1.15x | 27.99x |
| 2023 | $4.51 Billion | $3.75 Billion | $173.60 Million | 1.20x | 26.00x |
| 2024 | $4.68 Billion | $3.92 Billion | $182.95 Million | 1.19x | 25.60x |
| 2025 | $6.15 Billion | $4.14 Billion | $181.10 Million | 1.49x | 33.98x |
Competitor Companies of GALE by Market Capitalization
Companies near Galenica Sante AG in the global market cap rankings as of September 17, 2026. Review Galenica Sante AG (GALE) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Galenica Sante AG by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #249 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #541 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #642 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1204 globally with a market cap of $21.56 Billion USD ( AU$30.48 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #249 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $899.56 |
| #541 | Cencora Inc. | NYSE:COR | $50.53 Billion | $323.29 |
| #642 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $232.65 |
| #1204 | Sigma Healthcare Ltd | AU:SIG | $21.56 Billion | AU$2.64 |
Galenica Sante AG Historical Marketcap From 2017 to 2026
Between 2017 and today, Galenica Sante AG's market cap moved from $2.75 Billion to $ 5.20 Billion, with a yearly change of 8.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF5.20 Billion | -15.56% |
| 2025 | CHF6.15 Billion | +31.41% |
| 2024 | CHF4.68 Billion | +3.77% |
| 2023 | CHF4.51 Billion | -2.35% |
| 2022 | CHF4.62 Billion | +11.80% |
| 2021 | CHF4.13 Billion | +17.84% |
| 2020 | CHF3.51 Billion | -0.14% |
| 2019 | CHF3.51 Billion | +43.05% |
| 2018 | CHF2.46 Billion | -10.85% |
| 2017 | CHF2.75 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Galenica Sante AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.09 Billion USD |
| MoneyControl | $4.09 Billion USD |
| MarketWatch | $4.09 Billion USD |
| marketcap.company | $4.09 Billion USD |
| Reuters | $4.09 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Galenica Sante AG
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients … Read more